Welcome to the Pacific Edge Investor Centre. Here you will find useful information about being a shareholder of our company.
See the latest news and presentations, keep up to date with our newsletters and shareholder reports, find out when we are holding shareholder meetings and check up on our share price.
Pacific Edge is a publicy listed company on the NZX: listed as PEB.
- Value $00,000.000
- Volume 00,000
- Capitalisation $000,000
- Open $0.000
- Close $0.000
- High $0.000
- Low $0.000
Data up to date as of 00-00-0000 00:00
Another Of New Zealand’s Public Healthcare Providers, Hauora Tairawhiti, Adopts Cxbladder
Gisborne’s Hauora Tairāwhiti (Tairāwhiti District Health Board) to Implement Cxbladder Testing for Urology Referrals [read more]
Another New Zealand Public Healthcare Provider Signs Up to Cxbladder
Counties Manukau Health to Adopt Cxbladder Tests for Application Across the Clinical Pathway [read more]
Pacific Edge Attracts US Investment And Undertakes Share Placement
Cancer diagnostics company, Pacific Edge Limited, has accepted an investment offer of NZ$ 2.622 million from Manchester Management Company, LLC (MMC), a US privately owned fund specialising in biotech and life sciences investments. [read more]
Reports and Presentations
For further investor information on Pacific Edge our recent annual reports, investor presentations and investment research reports are available for download below
FY18 Full Year Results Conference Call Audio Commentary[9.6 MB]
FY18 Full Year Results Presentation[733 KB]